Yifei Mu
- Co-authors
- Shao‐Lan QinMing ZhongYang LuoMinhao YuQi YangZhengshi WangZhi‐Jie CongYan Zhang
- Topics
- Cancer-related molecular mechanisms research (4 papers)MicroRNA in disease regulation (3 papers)Ubiquitin and proteasome pathways (3 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Bioresource TechnologyJournal of Agricultural and Food ChemistryInternational Journal of Biological Macromolecules
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Yifei Mu
25 papers receiving 457 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 228
- Oncology 140
- Cancer Research 133
- Immunology 94
- Pulmonary and Respiratory Medicine 46
Countries citing papers authored by Yifei Mu
This map shows the geographic impact of Yifei Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifei Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifei Mu more than expected).
Fields of papers citing papers by Yifei Mu
This network shows the impact of papers produced by Yifei Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifei Mu. The network helps show where Yifei Mu may publish in the future.
Co-authorship network of co-authors of Yifei Mu
This figure shows the co-authorship network connecting the top 25 collaborators of Yifei Mu. A scholar is included among the top collaborators of Yifei Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifei Mu. Yifei Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 17 | |
| 5 | 7 | |
| 6 | 16 | |
| 7 | 10 | |
| 8 | 44 | |
| 9 | 27 | |
| 10 | 11 | |
| 11 | 68 | |
| 12 | 34 | |
| 13 | miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancer. | 29 |
| 14 | 31 | |
| 15 | [Efficacy of complete mesocolic excision in radical operation for right colon cancer]. | 2 |
| 16 | 17 | |
| 17 | 11 | |
| 18 | [Impact of lysosome-associated protein transmembrane-4 beta on proliferation and invasion of colorectal cancer]. | 1 |
| 19 | 20 | |
| 20 | 15 |
About Yifei Mu
Yifei Mu is a scholar working on Cancer Research, Transplantation and Oncology, having authored 27 papers that have together received 457 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (133 citations), Oncology (140 citations) and Immunology (94 citations). Yifei Mu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Shao‐Lan Qin, Ming Zhong, Yang Luo, Minhao Yu, Qi Yang, Zhengshi Wang, Ming Zhong, Zhi‐Jie Cong, Yan Zhang and Guangyao Ye. Their work appears in journals such as Bioresource Technology, Journal of Agricultural and Food Chemistry and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.